MeiraGTx Holdings (MGTX) Assets Average (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Assets Average came in at $217.0 million in Q4 2025, down 23.78% YoY from $284.6 million in Q4 2024, and up 11.78% on a QoQ basis from $194.1 million in Q3 2025.
MeiraGTx Holdings (MGTX) Assets Average (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Assets Average data on file, last reported at $217.0 million in Q4 2025.
- Quarterly Assets Average fell 23.78% year-over-year to $217.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $217.0 million (down 23.78% YoY) and the FY2025 annual result came in at $257.1 million, down 13.8% from the prior year.
- Assets Average rose to $217.0 million in Q4 2025, from $194.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $318.0 million in Q1 2024 to a low of $1.7 million in Q1 2021.
- A 5-year average of $157.5 million and a median of $163.6 million in 2022 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2021 — Assets Average jumped 11449.38% — and 2023, when it tumbled 65.44%.
- Tracing MGTX's Assets Average over 5 years: stood at $162.1 million in 2021, then gained by 0.51% to $162.9 million in 2022, then soared by 82.28% to $297.0 million in 2023, then fell by 4.16% to $284.6 million in 2024, then slipped by 23.78% to $217.0 million in 2025.
- The last three Assets Average figures came in at $217.0 million (Q4 2025), $194.1 million (Q3 2025), and $211.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 216.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 216.95 Mn |
| Sep 30, 2025 | 194.09 Mn |
| Jun 30, 2025 | 211.37 Mn |
| Mar 31, 2025 | 246.88 Mn |
| Dec 31, 2024 | 284.62 Mn |
| Sep 30, 2024 | 283.07 Mn |
| Jun 30, 2024 | 287.94 Mn |
| Mar 31, 2024 | 317.99 Mn |
| Dec 31, 2023 | 296.97 Mn |
| Sep 30, 2023 | 134.79 Mn |
| Jun 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | 160.70 Mn |
| Dec 31, 2022 | 162.92 Mn |
| Sep 30, 2022 | 7.54 Mn |
| Jun 30, 2022 | 8.03 Mn |
| Mar 31, 2022 | 164.37 Mn |
| Dec 31, 2021 | 162.10 Mn |
| Sep 30, 2021 | 3.61 Mn |
| Jun 30, 2021 | 2.45 Mn |
| Mar 31, 2021 | 1.66 Mn |